Flubromazepam

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Flubromazepam
Flubromazepam.svg
Clinical data
Routes of
administration
Oral
Legal status
Legal status
Pharmacokinetic data
Biological half-life 106 hours
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
Formula C15H10BrFN2O
Molar mass 333.16 g/mol
3D model (Jmol)

Flubromazepam is a benzodiazepine derivative which was first synthesized in 1960,[1] but was never marketed and did not receive any further attention or study until late 2012 when it appeared on the grey market as a novel designer drug.[2][3][4][5][6][7]

It is a structural analog of phenazepam in which the chlorine atom has been replaced by a fluorine atom.

An alternate isomer, 5-(2-bromophenyl)-7-fluoro-1,3-dihydro-2H-1,4-benzodiazepin-2-one, may have been sold under the same name.[2]

Alternate isomer

See also[edit]

References[edit]

  1. ^ US 3136815, "Amino substituted benzophenone oximes and derivatives thereof" 
  2. ^ a b Bjoern Moosmann; Laura M. Huppertz; Melanie Hutter; Armin Buchwald; Sascha Ferlaino; Volker Auwärter (November 2013). "Detection and identification of the designer benzodiazepine flubromazepam and preliminary data on its metabolism and pharmacokinetics". Journal of Mass Spectrometry. 48 (11): 1150–1159. doi:10.1002/jms.3279. PMID 24259203. 
  3. ^ B. Moosmann; M. Hutter; L. M. Huppertz; V. Auwärter. "Characterization of the designer benzodiazepines pyrazolam and flubromazepam and study on their detectability in human serum and urine samples" (PDF). Institute of Forensic Medicine, Forensic Toxicology, University Medical Center Freiburg, Freiburg, Germany. 
  4. ^ Lauren C. O'Connor; Hazel J. Torrance; Denise A. McKeown (March 2016). "ELISA Detection of Phenazepam, Etizolam, Pyrazolam, Flubromazepam, Diclazepam and Delorazepam in Blood Using Immunalysis® Benzodiazepine Kit". Journal of Analytical Toxicology. 40 (2): 159–161. doi:10.1093/jat/bkv122. PMID 26518230. 
  5. ^ "Flubromazepam". New Synthetic Drugs Database. 
  6. ^ Madeleine Pettersson Bergstrand; Anders Helander; Therese Hansson; Olof Beck (2016). "Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays". Drug Testing and Analysis. doi:10.1002/dta.2003. PMID 27366870. 
  7. ^ Høiseth, Gudrun; Tuv, Silja Skogstad; Karinen, Ritva (2016). "Blood concentrations of new designer benzodiazepines in forensic cases". Forensic Science International. 268: 35–38. doi:10.1016/j.forsciint.2016.09.006.